Business Wire4d
Bayer to Present New Prespecified Subgroup Analyses from Investigational Phase III FINEARTS-HF Trial in Patients with Heart Failure with LVEF ≥40% at AHA 2024
Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...
D.E. Shaw Takes $108 Million Short Bet on Bayer, Regulatory Filing Shows
LONDON/FRANKFURT (Reuters) - Hedge fund D.E. Shaw took a 102 million euro ($108 million) short bet against Bayer on Tuesday, ...
Morningstar6d
Bayer's Near-Term Outlook Dominated by Crop Science Uncertainty and Generic Pressures
Bayer's healthcare segment also includes a consumer healthcare business with leading brands Aspirin and Aleve ... While Eylea’s complex biologic structure and a longer-acting dose (with potential ...
Yen.com.gh6d
Bayer shares hit 20-yr low as problems pile up
Get your daily dose of sports news straight to your phone. Join YEN's Sports News channel on WhatsApp now! Bayer's shares ...